Ryan Deschner
Stock Analyst at Jefferies
(3.73)
# 202
Out of 5,347 analysts
13
Total ratings
80.00%
Success rate
81.23%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INZY Inozyme Pharma | Downgrades: Hold | 15 4 | 3.95 | 1.27% | 2 | May 16, 2025 | |
APLS Apellis Pharmaceutic... | Downgrades: Outperform | 75 52 | 16.93 | 207.15% | 1 | May 9, 2025 | |
LQDA Liquidia | Maintains: Strong Buy | 27 29 | 14.91 | 94.5% | 3 | May 9, 2025 | |
TRVI Trevi Therapeutics | Upgrades: Strong Buy | 9 29 | 6.52 | 344.79% | 2 | Mar 10, 2025 | |
ARDX Ardelyx | Reiterates: Strong Buy | 15 13 | 3.67 | 254.22% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 26 28 | 14.41 | 94.31% | 3 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 1 | Jun 18, 2024 |